The Canadian cannabis stocks continue to trade near the yearly lows and the Cannabis 2.0 rollout can’t start soon enough.
Last week saw a landmark decision by the U.S.
The vast majority of the Canadian cannabis sector gets beaten down almost every day. The Canadian cannabis sales aren’t living up to expectations …
Tilray’s (TLRY) year-to-date price chart does not make for pretty viewing. On a merciless downward trajectory, the embattled marijuana stock has shed almost …
The cannabis sector has seen an unusual pattern of executives agreeing to extended share lock-up extensions due presumably that insiders are looking to …
When a cannabis company makes an acquisition in Canada a few quarters following the CEO claiming the market is too expensive, investors should …
A lot of the Canadian cannabis LPs shunned the U.S.
It’s no question that the marijuana industry is a budding space. The industry saw $10.
This year hasn’t been a great one for medical cannabis provider Tilray (TLRY), to say the least. Tilray stock has been killed over …
The greatest challenge for Tilray (TLRY) is its inability to live up to the unwarranted hype that accompanied the aftermath of its IPO, …
